VIM and gastric cancer: We found that MLN4924 increased the expression of E-cadherin, an epithelial biomarker in a dosage-dependent manner in both gastric cancer cell lines, without affecting the levels of mesenchymal markers N-cadherin and Vimentin (Fig. 5c).